References
- Kaplow L. S. Cytochemistry of leukocyte alkaline phosphatase. Am. J. Clin. Pathol 1963; 39: 439–444
- Quaglino D., Hayhoe F. G. J. Haematological cytochemistry. 2nded. Churchill Livingstone, Edinburgh 1988; 432–433
- Brook J., Dreisbach P. B. Leukocyte alkaline phosphatase levels in multiple myeloma. J. Lab. Clin. Med. 1977; 90: 114–117
- Johansen P., Jensen M. K. Enzymecytochemistry and immunohistochemistry in monoclonal gammopathy and reactive plasmocytosis. Acta Pathologica and Microbiologica Scandinava (Section A) 1980; 88: 377–382
- Majumdar G., Hunt M., Singh A. K. Use of leucocyte alkaline phosphatase score in differentiating malignant from benign paraproteinaemias. J. Clin. Pathol. 1991; 44: 606–607
- Chikkappa G., Wang G. J., Santella D., Pasquale D. Granulocytecolony stimulating factor (G-CSF) induces synthesis of alkaline phosphatase in neutrophilic granulocytes of chronic myelogenous leukemia patients. Leukemia Res. 1986; 12: 491–494
- Yuo A., Kitagowa S., Okabe T., Urabe A., Komatsu Y., Itoh S., Takaku F. Recombinant human granulocyte-colony stimulating factor repairs abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia. Blood 1987; 70: 404–408
- Durie B. G. M., Salmon S. E. Multiple myeloma, macroglobulinemia and monoclonal gammopathies. Recent advances in hematology, A. V. Hoffbrand, M. C. Brown, J. Hisrch. Churchill Livingstone, Edinburgh 1977; 243–261
- Durie B. G. M., Salmon S. E. A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting features, response to treatment, and survival. Cancer 1975; 36: 842–854
- Dacie J. V., Lewis S. M. Practical haematology. 6th ed. Churchill Livingstone, Edinburgh 1988; 88
- Sieff C. A. Hematopoietic growth factors. J. Clin. Invest. 1987; 79: 1549–1555
- Cannistra S. A., Griffin J. D. Regulation of the production and function of granulocytes and monocytes. Sem. in Hematol. 1988; 25: 173–188
- Wachter H., Fuchs D., Hausen A., Reibbnegger G., Werner E. R. Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Advances in Clinical Chemistry 1989; 27: 81–141
- Klein B., Bataille R. Cytokine network in human multiple myeloma. Hematology/Oncology Clinics of North America 1992; 6: 273–284
- Wiktor-Jedrzejczak W., Bartocci A., Ferrante A., Ansari A. A., Sell K. W., Stanley E. R. Increased colony-stimulating factor-1 in patients with pre-leukemia, leukemia, and lymphoid malignancies. Blood 1991; 77: 1796–1801
- Nakamura M., Merchav S., Carter A., Ernst T. J., Demetri G. D., Furukawa Y., Anderson K. Expression of a novel 3–5-kb macrophace colony-stimulating factor transcript in human myeloma cells. J. Immunol. 1989; 143: 3543–3546
- Warren M. K., Ralph P. Macrophage groth factor CSF-Istimulates human monocyte production of interferon, tumor necrosis factor and colony-stimulating activity. J. Immunol. 1986; 137: 2281–2286
- Bataille R., Chappard D., Klein B. The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma. J. Clin. Lab. Res. 1992; 21: 283–287